Endothelial cell chemotactic factor derived from human glioma cell lines

Area of Science:

• Molecular Biology
• Oncology
• Cell Biology

Background:

• Malignant gliomas are aggressive brain tumors with significant unmet clinical needs.
• Tumor angiogenesis, the formation of new blood vessels, is critical for glioma growth and metastasis.
• Endothelial cell chemotaxis is a key process in angiogenesis.

Purpose of the Study:

• To investigate the production of endothelial cell chemotactic factors by human malignant glioma cell lines.
• To partially isolate and characterize a novel chemotactic factor derived from glioma cells.

Main Methods:

• Cultured human malignant glioma cell lines (U-373MG, U-251MG, U-105MG) to obtain conditioned medium.
• Utilized a 48-well microchemotaxis chamber to assess endothelial cell chemotactic activity.
• Employed heparin-affinity chromatography for partial isolation and characterization, including molecular weight estimation and sensitivity to heat, acid, trypsin, and protein synthesis inhibition.

Main Results:

• U-373MG cells exhibited the highest chemotactic activity for human umbilical vein endothelial cells.
• The chemotactic factor was identified as a protein with a molecular weight greater than 200 kD.
• The factor's activity was reduced by inhibiting tumor protein synthesis, heating, acid exposure, and trypsin digestion, and it lacked mitogenic activity.

Conclusions:

• Human malignant glioma cells secrete a novel, high-molecular-weight protein that acts as a potent chemoattractant for endothelial cells.
• This glioma-derived endothelial cell chemotactic factor is distinct from previously identified factors like fibronectin.
• The findings suggest a significant role for this newly identified factor in glioma-associated angiogenesis and tumor progression.